| No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
| 1 |
rs10926476 |
chr1:241554603-241554604 |
Weak transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
| 2 |
rs539910728 |
chr1:241554621-241554622 |
Weak transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 3 |
rs560298042 |
chr1:241554664-241554665 |
Weak transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 4 |
rs141243847 |
chr1:241554671-241554672 |
Weak transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 5 |
rs545967351 |
chr1:241554681-241554682 |
Weak transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 6 |
rs562685297 |
chr1:241554687-241554688 |
Weak transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 7 |
rs72762444 |
chr1:241554698-241554699 |
Weak transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 8 |
rs374902481 |
chr1:241554728-241554729 |
Weak transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 9 |
rs191661212 |
chr1:241554751-241554752 |
Weak transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 10 |
rs568429851 |
chr1:241554763-241554764 |
Weak transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 11 |
rs146946260 |
chr1:241554804-241554805 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 12 |
rs547529755 |
chr1:241554806-241554807 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 13 |
rs148034767 |
chr1:241554808-241554809 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 14 |
rs182669589 |
chr1:241554809-241554810 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 15 |
rs140853847 |
chr1:241554856-241554857 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 16 |
rs150137656 |
chr1:241554863-241554864 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 17 |
rs138665360 |
chr1:241554864-241554865 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 18 |
rs187306584 |
chr1:241554885-241554886 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 19 |
rs141825168 |
chr1:241554890-241554891 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 20 |
rs540332297 |
chr1:241554911-241554912 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 21 |
rs78446363 |
chr1:241554940-241554941 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 22 |
rs576868185 |
chr1:241554951-241554952 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 23 |
rs146065517 |
chr1:241555024-241555025 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 24 |
rs562688708 |
chr1:241555025-241555026 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 25 |
rs374493872 |
chr1:241555032-241555033 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 26 |
rs368433676 |
chr1:241555109-241555110 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 27 |
rs138792838 |
chr1:241555147-241555148 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 28 |
rs142045508 |
chr1:241555160-241555161 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 29 |
rs371737006 |
chr1:241555216-241555217 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 30 |
rs562067310 |
chr1:241555241-241555242 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 31 |
rs113038780 |
chr1:241555282-241555283 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 32 |
rs547763440 |
chr1:241555348-241555349 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 33 |
rs115593054 |
chr1:241555357-241555358 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 34 |
rs539733040 |
chr1:241555405-241555406 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 35 |
rs192200776 |
chr1:241555428-241555429 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 36 |
rs148531994 |
chr1:241555436-241555437 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 37 |
rs371267762 |
chr1:241555438-241555439 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 38 |
rs557799229 |
chr1:241555453-241555454 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 39 |
rs185242798 |
chr1:241555484-241555485 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 40 |
rs77380211 |
chr1:241555489-241555490 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 41 |
rs190482626 |
chr1:241555492-241555493 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 42 |
rs116777145 |
chr1:241555514-241555515 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 43 |
rs533597058 |
chr1:241555542-241555543 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 44 |
rs553706544 |
chr1:241555573-241555574 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 45 |
rs114825038 |
chr1:241555587-241555588 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 46 |
rs539486336 |
chr1:241555602-241555603 |
Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 47 |
rs150661505 |
chr1:241555671-241555672 |
Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 48 |
rs193102537 |
chr1:241555681-241555682 |
Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 49 |
rs542156790 |
chr1:241555748-241555749 |
Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 50 |
rs141044854 |
chr1:241555818-241555819 |
Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|